170 related articles for article (PubMed ID: 28682065)
1. Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of Na
Swain NA; Batchelor D; Beaudoin S; Bechle BM; Bradley PA; Brown AD; Brown B; Butcher KJ; Butt RP; Chapman ML; Denton S; Ellis D; Galan SRG; Gaulier SM; Greener BS; de Groot MJ; Glossop MS; Gurrell IK; Hannam J; Johnson MS; Lin Z; Markworth CJ; Marron BE; Millan DS; Nakagawa S; Pike A; Printzenhoff D; Rawson DJ; Ransley SJ; Reister SM; Sasaki K; Storer RI; Stupple PA; West CW
J Med Chem; 2017 Aug; 60(16):7029-7042. PubMed ID: 28682065
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Potent, Selective, and State-Dependent Na
Ramdas V; Talwar R; Kanoje V; Loriya RM; Banerjee M; Patil P; Joshi AA; Datrange L; Das AK; Walke DS; Kalhapure V; Khan T; Gote G; Dhayagude U; Deshpande S; Shaikh J; Chaure G; Pal RR; Parkale S; Suravase S; Bhoskar S; Gupta RV; Kalia A; Yeshodharan R; Azhar M; Daler J; Mali V; Sharma G; Kishore A; Vyawahare R; Agarwal G; Pareek H; Budhe S; Nayak A; Warude D; Gupta PK; Joshi P; Joshi S; Darekar S; Pandey D; Wagh A; Nigade PB; Mehta M; Patil V; Modi D; Pawar S; Verma M; Singh M; Das S; Gundu J; Nemmani K; Bock MG; Sharma S; Bakhle D; Kamboj RK; Palle VP
J Med Chem; 2020 Jun; 63(11):6107-6133. PubMed ID: 32368909
[TBL] [Abstract][Full Text] [Related]
3. The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na(v)1.7.
Sun S; Jia Q; Zenova AY; Chafeev M; Zhang Z; Lin S; Kwan R; Grimwood ME; Chowdhury S; Young C; Cohen CJ; Oballa RM
Bioorg Med Chem Lett; 2014 Sep; 24(18):4397-4401. PubMed ID: 25176194
[TBL] [Abstract][Full Text] [Related]
4. Sulfonamides as Selective Na
Weiss MM; Dineen TA; Marx IE; Altmann S; Boezio A; Bregman H; Chu-Moyer M; DiMauro EF; Feric Bojic E; Foti RS; Gao H; Graceffa R; Gunaydin H; Guzman-Perez A; Huang H; Huang L; Jarosh M; Kornecook T; Kreiman CR; Ligutti J; La DS; Lin MJ; Liu D; Moyer BD; Nguyen HN; Peterson EA; Rose PE; Taborn K; Youngblood BD; Yu V; Fremeau RT
J Med Chem; 2017 Jul; 60(14):5969-5989. PubMed ID: 28287723
[TBL] [Abstract][Full Text] [Related]
5. The discovery of tetrahydropyridine analogs as hNav1.7 selective inhibitors for analgesia.
Wu W; Li Z; Yang G; Teng M; Qin J; Hu Z; Hou L; Shen L; Dong H; Zhang Y; Li J; Chen S; Tian J; Zhang J; Ye L
Bioorg Med Chem Lett; 2017 May; 27(10):2210-2215. PubMed ID: 28385504
[TBL] [Abstract][Full Text] [Related]
6. Discovery of morpholine-based aryl sulfonamides as Na
Wu YJ; Guernon J; McClure A; Venables B; Rajamani R; Robbins KJ; Knox RJ; Matchett M; Pieschl RL; Herrington J; Bristow LJ; Meanwell NA; Olson R; Thompson LA; Dzierba C
Bioorg Med Chem Lett; 2018 Mar; 28(5):958-962. PubMed ID: 29439904
[TBL] [Abstract][Full Text] [Related]
7. Design of Conformationally Constrained Acyl Sulfonamide Isosteres: Identification of N-([1,2,4]Triazolo[4,3- a]pyridin-3-yl)methane-sulfonamides as Potent and Selective hNa
Focken T; Chowdhury S; Zenova A; Grimwood ME; Chabot C; Sheng T; Hemeon I; Decker SM; Wilson M; Bichler P; Jia Q; Sun S; Young C; Lin S; Goodchild SJ; Shuart NG; Chang E; Xie Z; Li B; Khakh K; Bankar G; Waldbrook M; Kwan R; Nelkenbrecher K; Karimi Tari P; Chahal N; Sojo L; Robinette CL; White AD; Chen CA; Zhang Y; Pang J; Chang JH; Hackos DH; Johnson JP; Cohen CJ; Ortwine DF; Sutherlin DP; Dehnhardt CM; Safina BS
J Med Chem; 2018 Jun; 61(11):4810-4831. PubMed ID: 29737846
[TBL] [Abstract][Full Text] [Related]
8. Identification of Selective Acyl Sulfonamide-Cycloalkylether Inhibitors of the Voltage-Gated Sodium Channel (Na
Sun S; Jia Q; Zenova AY; Wilson MS; Chowdhury S; Focken T; Li J; Decker S; Grimwood ME; Andrez JC; Hemeon I; Sheng T; Chen CA; White A; Hackos DH; Deng L; Bankar G; Khakh K; Chang E; Kwan R; Lin S; Nelkenbrecher K; Sellers BD; DiPasquale AG; Chang J; Pang J; Sojo L; Lindgren A; Waldbrook M; Xie Z; Young C; Johnson JP; Robinette CL; Cohen CJ; Safina BS; Sutherlin DP; Ortwine DF; Dehnhardt CM
J Med Chem; 2019 Jan; 62(2):908-927. PubMed ID: 30499663
[TBL] [Abstract][Full Text] [Related]
9. Sulfonamides as Selective Na
Graceffa RF; Boezio AA; Able J; Altmann S; Berry LM; Boezio C; Butler JR; Chu-Moyer M; Cooke M; DiMauro EF; Dineen TA; Feric Bojic E; Foti RS; Fremeau RT; Guzman-Perez A; Gao H; Gunaydin H; Huang H; Huang L; Ilch C; Jarosh M; Kornecook T; Kreiman CR; La DS; Ligutti J; Milgram BC; Lin MJ; Marx IE; Nguyen HN; Peterson EA; Rescourio G; Roberts J; Schenkel L; Shimanovich R; Sparling BA; Stellwagen J; Taborn K; Vaida KR; Wang J; Yeoman J; Yu V; Zhu D; Moyer BD; Weiss MM
J Med Chem; 2017 Jul; 60(14):5990-6017. PubMed ID: 28324649
[TBL] [Abstract][Full Text] [Related]
10. Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors.
DiMauro EF; Altmann S; Berry LM; Bregman H; Chakka N; Chu-Moyer M; Bojic EF; Foti RS; Fremeau R; Gao H; Gunaydin H; Guzman-Perez A; Hall BE; Huang H; Jarosh M; Kornecook T; Lee J; Ligutti J; Liu D; Moyer BD; Ortuno D; Rose PE; Schenkel LB; Taborn K; Wang J; Wang Y; Yu V; Weiss MM
J Med Chem; 2016 Sep; 59(17):7818-39. PubMed ID: 27441383
[TBL] [Abstract][Full Text] [Related]
11. Clinical Micro-Dose Studies to Explore the Human Pharmacokinetics of Four Selective Inhibitors of Human Nav1.7 Voltage-Dependent Sodium Channels.
Jones HM; Butt RP; Webster RW; Gurrell I; Dzygiel P; Flanagan N; Fraier D; Hay T; Iavarone LE; Luckwell J; Pearce H; Phipps A; Segelbacher J; Speed B; Beaumont K
Clin Pharmacokinet; 2016 Jul; 55(7):875-887. PubMed ID: 26895021
[TBL] [Abstract][Full Text] [Related]
12. Highly potent and selective Na
Storer RI; Pike A; Swain NA; Alexandrou AJ; Bechle BM; Blakemore DC; Brown AD; Castle NA; Corbett MS; Flanagan NJ; Fengas D; Johnson MS; Jones LH; Marron BE; Payne CE; Printzenhoff D; Rawson DJ; Rose CR; Ryckmans T; Sun J; Theile JW; Torella R; Tseng E; Warmus JS
Bioorg Med Chem Lett; 2017 Nov; 27(21):4805-4811. PubMed ID: 29029933
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Acyl-sulfonamide Na
Safina BS; McKerrall SJ; Sun S; Chen CA; Chowdhury S; Jia Q; Li J; Zenova AY; Andrez JC; Bankar G; Bergeron P; Chang JH; Chang E; Chen J; Dean R; Decker SM; DiPasquale A; Focken T; Hemeon I; Khakh K; Kim A; Kwan R; Lindgren A; Lin S; Maher J; Mezeyova J; Misner D; Nelkenbrecher K; Pang J; Reese R; Shields SD; Sojo L; Sheng T; Verschoof H; Waldbrook M; Wilson MS; Xie Z; Young C; Zabka TS; Hackos DH; Ortwine DF; White AD; Johnson JP; Robinette CL; Dehnhardt CM; Cohen CJ; Sutherlin DP
J Med Chem; 2021 Mar; 64(6):2953-2966. PubMed ID: 33682420
[TBL] [Abstract][Full Text] [Related]
14. Structure- and Ligand-Based Discovery of Chromane Arylsulfonamide Na
McKerrall SJ; Nguyen T; Lai KW; Bergeron P; Deng L; DiPasquale A; Chang JH; Chen J; Chernov-Rogan T; Hackos DH; Maher J; Ortwine DF; Pang J; Payandeh J; Proctor WR; Shields SD; Vogt J; Ji P; Liu W; Ballini E; Schumann L; Tarozzo G; Bankar G; Chowdhury S; Hasan A; Johnson JP; Khakh K; Lin S; Cohen CJ; Dehnhardt CM; Safina BS; Sutherlin DP
J Med Chem; 2019 Apr; 62(8):4091-4109. PubMed ID: 30943032
[TBL] [Abstract][Full Text] [Related]
15. The Selective Nav1.7 Inhibitor, PF-05089771, Interacts Equivalently with Fast and Slow Inactivated Nav1.7 Channels.
Theile JW; Fuller MD; Chapman ML
Mol Pharmacol; 2016 Nov; 90(5):540-548. PubMed ID: 27587537
[TBL] [Abstract][Full Text] [Related]
16. The discovery and optimization of benzimidazoles as selective Na
Brown AD; Bagal SK; Blackwell P; Blakemore DC; Brown B; Bungay PJ; Corless M; Crawforth J; Fengas D; Fenwick DR; Gray V; Kemp M; Klute W; Malet Sanz L; Miller D; Murata Y; Payne CE; Skerratt S; Stevens EB; Warmus JS
Bioorg Med Chem; 2019 Jan; 27(1):230-239. PubMed ID: 30538065
[TBL] [Abstract][Full Text] [Related]
17. In silico exploration of aryl sulfonamide analogs as voltage-gated sodium channel 1.7 inhibitors by using 3D-QSAR, molecular docking study, and molecular dynamics simulations.
Wang M; Wang Y; Kong D; Jiang H; Wang J; Cheng M
Comput Biol Chem; 2018 Dec; 77():214-225. PubMed ID: 30359866
[TBL] [Abstract][Full Text] [Related]
18. Discovery of selective, orally bioavailable, N-linked arylsulfonamide Na
Roecker AJ; Egbertson M; Jones KLG; Gomez R; Kraus RL; Li Y; Koser AJ; Urban MO; Klein R; Clements M; Panigel J; Daley C; Wang J; Finger EN; Majercak J; Santarelli V; Gregan I; Cato M; Filzen T; Jovanovska A; Wang YH; Wang D; Joyce LA; Sherer EC; Peng X; Wang X; Sun H; Coleman PJ; Houghton AK; Layton ME
Bioorg Med Chem Lett; 2017 May; 27(10):2087-2093. PubMed ID: 28389149
[TBL] [Abstract][Full Text] [Related]
19. The discovery of benzoxazine sulfonamide inhibitors of Na
La DS; Peterson EA; Bode C; Boezio AA; Bregman H; Chu-Moyer MY; Coats J; DiMauro EF; Dineen TA; Du B; Gao H; Graceffa R; Gunaydin H; Guzman-Perez A; Fremeau R; Huang X; Ilch C; Kornecook TJ; Kreiman C; Ligutti J; Jasmine Lin MH; McDermott JS; Marx I; Matson DJ; McDonough SI; Moyer BD; Nho Nguyen H; Taborn K; Yu V; Weiss MM
Bioorg Med Chem Lett; 2017 Aug; 27(15):3477-3485. PubMed ID: 28629594
[TBL] [Abstract][Full Text] [Related]
20. Discovery of aminocyclohexene analogues as selective and orally bioavailable hNav1.7 inhibitors for analgesia.
Teng M; Wu W; Li Z; Yang G; Qin J; Wang Y; Hu Z; Dong H; Hou L; Hu G; Shen L; Zhang Y; Li J; Chen S; Tian J; Ye L; Zhang J; Wang H
Bioorg Med Chem Lett; 2017 Nov; 27(22):4979-4984. PubMed ID: 29037948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
